Global Brain Monitoring Market was valued at US$ XX million in 2020 and is anticipated to reach US$ XX million by 2027 displaying an elevated CAGR of XX% over the forecast period (2021-2027). Brain monitoring devices are used to monitor and diagnose neurological conditions by exploring the structure and function of the brain. This process involves the use of several brain monitoring devices such as electroencephalography devices, intracranial pressure monitors, and magnetoencephalography to track brain functions. In addition, these devices help monitor neural and electrical activity in the brain. At present, there is an increase in the demand for electroencephalography devices among healthcare providers.
The presence of high incidence rates of diseases leading to brain disorders such as epilepsy, Alzheimer's disease, brain tumors, and multiple sclerosis will also serve this market as high impact rendering drivers. According to the estimates of the WHO in 2011 the global prevalence of epilepsy and multiple sclerosis was calculated at 50 million and 2.5 million respectively. This alarming statistic goes to show the dire need for brain monitoring devices in the global healthcare industry today. The market offers a wide range of devices to treat the abnormal brain activities and restore its functioning, depending on the case.
This statistic shows the rate of death in the U.S. with epilepsy as the underlying cause from 2015 to 2019. In 2019, the death rate for epilepsy was 0.5 per 100,000 population, a slight increase from a rate of 0.4 in the year 2015.
Epilepsy is a general term used to describe a group of related neurological disorders characterized by recurrent seizures. Seizures among epileptics can vary in frequency and seriousness and can last a few seconds or a few minutes. Some of the most common seizure triggers among epileptics include bright flashing lights, stress, lack of sleep, illness or fever, and alcohol, caffeine, and other drugs. In most cases, the cause of epilepsy is unknown, but the disorder can result from stroke, brain injury, brain tumors, and serious illness or very high fever. Approximately 1.1 percent of the population of the U.S. currently lives with epilepsy, with the disorder occurring equally among men and women.
Natus Medical, Inc., Nihon Kohden Corporation, Philips Healthcare, GE Healthcare, Siemens Healthineers, Compumedics, Ltd., Medtronic, CAS Medical Systems, Dr?gerwerk AG & Co. KGaA and Masimo Corporation are some of the prominent players operating in the global brain monitoring market. Several M&A's along with partnerships have been undertaken by these players to develop new and advanced products.
Insights Presented in the Report
"Amongst product, devices segment holds the major share"
Based on product, the Brain Monitoring market is segmented into devices and accessories. The devices segment held the largest share of the brain monitoring market in 2019. This is mainly due to the rising incidence of neurological, neurodegenerative, psychotic, and sleep disorders, the need for early diagnosis, the availability of innovative portable and wearable home-based monitoring devices, and increasing patient awareness.
"Amongst disease, the traumatic brain injury (TBI) segment holds the major share"
Based on disease, the brain monitoring market is segmented into traumatic brain injury (TBI), stroke, dementia, headache disorders, sleep disorders, Parkinson's disease, epilepsy, Huntington's disease, and other diseases. Traumatic brain injury (TBI) holds the largest share of the brain monitoring market by a medical condition. A major factor responsible for the large share of this market segment is the growing incidence of TBIs across the globe, leading to high demand for the management of these cases, thus requiring the intensive use of brain monitoring devices.
Amongst procedure, the non-invasive segment is projected to show fastest growth"
Depending on procedure, the market is categorized into invasive and non-invasive. The non-invasive segment is projected to show fastest growth during the forecast period, due to rise in incidences of traumatic brain injuries, high acceptance rate of minimally invasive devices, and low risk of mortality. This increases the demand for these products that propels the market growth.
"Amongst end-user, the hospitals segment holds the major share"
Based on end-users, the global brain monitoring devices market is segmented into hospitals, neurology centers, diagnostic centers, ASCs & clinics, and other end users. The hospital segment held the largest share of the global brain monitoring market in 2019. Brain monitoring is a complex process, requiring expensive and advanced devices and equipment that are mainly found in hospitals. Hospitals also see a considerably larger inflow of patients as compared to small clinics and other end users. Additionally, brain monitoring devices pose a considerable burden in terms of maintenance expenses on healthcare facilities; hospitals, more than other end-users, can bear such costs. Hence, brain monitoring devices are mostly used in hospitals, which consequently account for the largest share of this market segment.
"North America signifies one of the largest markets of Brain Monitoring market"
For a better understanding of the market dynamics of the Brain Monitoring market, a detailed analysis was conducted for different regions across the globe including North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, and Rest of APAC), Rest of World has been conducted. North America is expected to dominate the Brain Monitoring market due to growing incidence of neurological diseases, a growing number of clinical trials of brain monitoring products, and the availability of medical reimbursement in the US. However, Asia-Pacific is expected to experience the highest growth rate during the forecast period, due to increase in number of geriatric population and rise in purchasing power of countries in the region.
Reasons to buy this report:
- The study includes market sizing and forecasting analysis validated by authenticated key industry experts
- The report presents a quick review of overall industry performance at one glance
- The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
- Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
- The study comprehensively covers the market across different segments
- Deep dive regional level analysis of the industry
Customization Options:
The Brain Monitoring market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
Brain monitoring devices are used to monitor and diagnose neurological conditions by exploring the structure and function of the brain. This process involves the use of several brain monitoring devices such as electroencephalography devices, intracranial pressure monitors, and magnetoencephalography to track brain functions. In addition, these devices help monitor neural and electrical activity in the brain. At present, there is an increase in the demand for electroencephalography devices among healthcare providers.
The presence of high incidence rates of diseases leading to brain disorders such as epilepsy, Alzheimer's disease, brain tumors, and multiple sclerosis will also serve this market as high impact rendering drivers. According to the estimates of the WHO in 2011 the global prevalence of epilepsy and multiple sclerosis was calculated at 50 million and 2.5 million respectively. This alarming statistic goes to show the dire need for brain monitoring devices in the global healthcare industry today. The market offers a wide range of devices to treat the abnormal brain activities and restore its functioning, depending on the case.
The growth of this market is driven owing to increasing incidence and prevalence of neurological disorders, rising awareness of neurodegenerative diseases and growth in the number of traumatic brain injuries. For instance, According to WHO data, in September 2019, around 50 million people are affected by dementia globally, with nearly 10 million new cases registered each year. It is one of the major causes of disability and dependency among older people worldwide. Also, in June 2019, globally, the number of people affected with epilepsy was approximately 50 million; of this, nearly 80% live in low- and middle-income countries according to WHO data.
Based on product, the Brain Monitoring market is segmented into devices and accessories. The devices segment held the largest share of the brain monitoring market in 2019. This is mainly due to the rising incidence of neurological, neurodegenerative, psychotic, and sleep disorders, the need for early diagnosis, the availability of innovative portable and wearable home-based monitoring devices, and increasing patient awareness.
Based on disease, the brain monitoring market is segmented into traumatic brain injury (TBI), stroke, dementia, headache disorders, sleep disorders, Parkinson's disease, epilepsy, Huntington's disease, and other diseases. Traumatic brain injury (TBI) holds the largest share of the brain monitoring market by a medical condition. A major factor responsible for the large share of this market segment is the growing incidence of TBIs across the globe, leading to high demand for the management of these cases, thus requiring the intensive use of brain monitoring devices.
Depending on procedure, the market is categorized into invasive and non-invasive. The non-invasive segment is projected to show fastest growth during the forecast period, due to rise in incidences of traumatic brain injuries, high acceptance rate of minimally invasive devices, and low risk of mortality. This increases the demand for these products that propels the market growth.
Based on end-users, the global brain monitoring devices market is segmented into hospitals, neurology centers, diagnostic centers, ASCs & clinics, and other end users. The hospital segment held the largest share of the global brain monitoring market in 2019. Brain monitoring is a complex process, requiring expensive and advanced devices and equipment that are mainly found in hospitals. Hospitals also see a considerably larger inflow of patients as compared to small clinics and other end users. Additionally, brain monitoring devices pose a considerable burden in terms of maintenance expenses on healthcare facilities; hospitals, more than other end-users, can bear such costs. Hence, brain monitoring devices are mostly used in hospitals, which consequently account for the largest share of this market segment.
For a better understanding of the market adoption, report provide detailed analysis for major region and countries including North America (US, Canada, Rest of North America), Europe (Germany, France, Spain, Italy, United Kingdom, Rest of Europe), Asia-Pacific (China, Japan, India, South Korea and Rest of APAC), and Rest of World. North America is expected to dominate the Brain Monitoring market due to growing incidence of neurological diseases, a growing number of clinical trials of brain monitoring products, and the availability of medical reimbursement in the US. However, Asia-Pacific is expected to experience the highest growth rate during the forecast period, due to increase in number of geriatric population and rise in purchasing power of countries in the region.
Some of the major players operating in the market include Natus Medical, Inc., Nihon Kohden Corporation, Philips Healthcare, GE Healthcare, Siemens Healthineers, Compumedics, Ltd., Medtronic, CAS Medical Systems, Dr?gerwerk AG & Co. KGaA and Masimo Corporation.
Table of Contents
1.
Natus Medical
Inc.
Nihon Kohden Corporation
Philips Healthcare
GE Healthcare
Siemens Healthineers
Compumedics
Ltd.
Medtronic
CAS Medical Systems
Dr